Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis

Clinical trial NCT01172938 · COMPLETED

Trial details

NCT number: NCT01172938
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Psoriatic Arthritis

Start date: 2010-06-02
Primary completion: 2012-04-27
Enrollment: 504

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.